|
|
Toshiba Features New 3T MR System at RSNA
3T System will Result in Higher Resolution Images and Increased Diagnostic Accuracy CHICAGO, Nov. 28, 2006 – Toshiba America Medical Systems, Inc. today announced it will preview its first 3-Tesla (3T) magnetic resonance (MR) system as a works-in-progress at the Radiological Society of North America’s (RSNA) annual meeting in Chicago, Nov. 26-Dec. 1, 2006. Toshiba’s development of a 3T product reinforces the company’s long-term commitment to the MR marketplace. Developed based on the popular EXCELART Vantage™ platform, the new 3T system boasts a revolutionary new magnet design and short-bore combination that deliver the high homogeneity customers expect from Toshiba’s line of MR technologies. The 3T system will be powered by Atlas technology, which also was introduced this year at RSNA. In addition, the new system features Toshiba’s patented Pianissimo™ technology, which reduces acoustic noise – solving the primary problem facing 3T imaging today of comfortably imaging patients. “We’ve dedicated a lot of time and resources to develop a 3T system that would not just meet, but exceed the expectations of our customers,” said Bob Giegerich, director, MR Business Unit, Toshiba. “Because of the system’s design, our 3T system will afford researchers and clinicians high image quality to ensure more accurate information, earlier diagnosis and more effective treatment." Higher spatial resolution at 3T and short acquisition times is the key to faster scanning and increased diagnostic accuracy. Toshiba’s 3T MR system will include whole-body imaging and spectroscopy that will more aggressively capture information not obtainable with 1.5T MR systems. With higher resolution images, the 3T MR system will make it possible to image finer anatomical structures while maintaining superior image quality. For more information about Toshiba’s 3T MR system, please visit booth #1129 (South Building, Hall A) at RSNA in Chicago, Nov. 26-Dec. 1, 2006. Vantage MRI: Unmatched Clinical Performance Featuring some of the most advanced MRI applications available in the industry, the Vantage offers a wide range of optional packages for cardiac imaging, including advanced Echo Planar Imaging, Diffusion and Perfusion Imaging, Peripheral Angiography and Fresh Blood Imaging, SuperFASE (Fast Advanced Spin Echo) imaging and Body Vision. In addition, Toshiba’s SPEEDER parallel imaging allows for increased acquisition speed and reduced examination times. With Toshiba's patented Pianissimo technology, the Vantage dramatically reduces acoustic noise, the most significant cause of patient discomfort during an MRI exam, and enables clinicians to better utilize all of the system's high-field MRI capabilities. About Toshiba With headquarters in Tustin, Calif., Toshiba America Medical Systems markets, sells, distributes and services diagnostic imaging systems, and coordinates clinical diagnostic imaging research for all modalities in the United States. Toshiba Medical Systems Corporation, an independent group company of Toshiba Corporation, is a global leading provider of diagnostic medical imaging systems and comprehensive medical solutions, such as CT, X-ray, Ultrasound, Nuclear Medicine, MRI and information systems. Toshiba Corporation is a leader in information and communications systems, electronic components, consumer products, and power systems. Toshiba has approximately 161,000 employees worldwide and annual sales of $54 billion. Source: Toshiba America Medical Systems, Inc. |
Angioplasty.Org Home • PatientCenter
this press release is posted as a reader
service by Angioplasty.org,
an editorially independent informational health
site
which has received unrestricted educational grants from
Medtronic plc,
TCROSS NEWS, Toshiba
America
Medical Systems, Volcano
Corporation, Terumo
Medical Corporation
Cardium Therapeutics, Inc. and Lenox Hill Heart and Vascular Institute of NY
All content, including text, photos and video
©Copyright Venture Digital LLC 1996-2021
